(Q45353696)

13 December 2017

title

In vitro activity of extracts of Persea americana leaves on acyclovir-resistant and phosphonoacetic resistant Herpes simplex virus (English)

1 reference

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

13 December 2017

1 reference

1 reference

1 reference

inferred from

reverse claim

(2R,3R,5R,6S)-heptane-1,2,3,4,5,6,7-heptol

1 reference

1 reference

M M Miranda

1

1 reference

13 December 2017

A P Almeida

2

1 reference

13 December 2017

S S Costa

3

1 reference

13 December 2017

M G Santos

4

1 reference

13 December 2017

M H Lagrota

5

1 reference

13 December 2017

M D Wigg

6

1 reference

13 December 2017

publication date

1 December 1997

1 reference

13 December 2017

1 reference

13 December 2017

volume

4

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

347-352

1 reference

Antiviral therapy: current concepts and practices

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Activity of some flavonoids against viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Resistance of herpesviruses to antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Mechanisms of herpes virus resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Antiviral effect of flavonoids on human viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Occurrence and characterization of acyclovir‐resistant herpes simplex virus isolates: Report on a two—year sensitivity screening survey

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

Antiviral activity of flavones and potentiation by ascorbate

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2897%2980045-1

7 January 2021

10.1016/S0944-7113(97)80045-1

Identifiers

DOI

1 reference

13 December 2017

1 reference